Magnerot

Magnesium gluconate, the active ingredient in Magnerot, is a magnesium supplement presented as a solution for intramuscular and intravenous use. It is used to correct magnesium deficiency and hypomagnesemia in patients who require parenteral therapy.

GNH USA supplies Magnerot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnerot is a magnesium supplement indicated for conditions related to low magnesium levels.

- Magnesium deficiency: restores normal serum magnesium concentrations. - Hypomagnesemia: corrects acute or chronic low magnesium states, supporting neuromuscular and cardiac function. - Post‑operative electrolyte management: helps maintain electrolyte balance after surgery.

Adverse reactions may occur with parenteral magnesium gluconate administration.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Flushing: transient redness and warmth. - Hypotension: temporary drop in blood pressure. - Nausea: mild gastrointestinal upset. - Dizziness: sensation of light‑headedness. - Headache: mild to moderate headache.

Serious or Rare Side Effects: - Hypermagnesemia: excessive serum magnesium leading to cardiac arrhythmia. - Respiratory depression: reduced breathing effort in severe cases. - Severe allergic reaction: anaphylaxis with rash, swelling, or bronchospasm. - Cardiac arrest: rare but life‑threatening event. - Muscle weakness: profound neuromuscular blockade. - Renal failure exacerbation: worsening kidney function due to reduced magnesium clearance.

Magnerot should be used with attention to patient‑specific factors and proper handling.

- Renal impairment: assess serum magnesium and adjust dose. - Cardiac disease: monitor ECG and blood pressure during infusion. - Electrolyte imbalance: correct concurrent calcium or potassium abnormalities. - Concomitant neuromuscular blockers: avoid potentiation of muscle relaxation. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Magnerot may interact with several medications; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Neuromuscular blocking agents: may potentiate muscle relaxation. - Calcium channel blockers: additive hypotensive effect. - Quinidine: increased risk of arrhythmia.

Moderate Interactions (Monitor Closely): - Loop diuretics: enhance renal magnesium loss. - ACE inhibitors: may alter electrolyte balance. - Antibiotics (e.g., tetracyclines): potential reduction in absorption when oral forms are used.